Substance misuse affects millions of Americans every year. The AMA is committed to addressing the root causes of substance misuse in America.
Federal Advocacy
AMA Advocacy Insights webinar series examines key advocacy issues from the federal and state levels impacting patients and physicians.
Publications & Newsletters
The news: FDA takes e-cigarettes Juul off the market, antibody response to Omicron subvariants, USPSTF on supplements in prevention of CVD, cancer and more.
Press Releases
The AMA applauds the FDA’s decision today ordering the removal of all JUUL Labs Inc. e-cigarette products from the U.S. market.
In the news: OTC medication recall, new EPA health advisories, Moderna COVID-19 vaccine for children, impact of binge drinking after age 30 and more.
The AMA today adopted new policy calling on states to expunge criminal records of people who were arrested or convicted of cannabis-related offenses.
In the news: CVD risk in childhood cancer survivors, coffee may help protect the kidneys, smoking frequency and nicotine dependence in teens and more.
Leadership
Alan Nelson, MD, was AMA president in 1989–1990 and joined the House of Delegates in 1972. Discover the changes he’s seen and how the AMA made him proud.
Patient Support & Advocacy
The AMA advocates at the federal and state levels on key health care issues impacting patients and physicians. See updates of our some of our recent efforts.